Aesthetic pharmaceutical company Croma Pharma has unveiled Exprecell, a new medical device designed for the preparation of autologous platelet-rich plasma (PRP). The MDR-approved, all-in-one system is used to prepare both
Aesthetic nurse Kate Monteith-Ross discusses the role of exosomes and energy-based devices for treating hyperpigmentation Hyperpigmentation and hypopigmentation are significant dermatological concerns that can arise as complications following various therapeutic interventions, including the use of energy-based device treatments. These dyschromias …
Dr Edward Robinson discusses a combination approach to regenerative aesthetics using PRP and PRF in synergy with other aesthetic treatments Regenerative treatments have emerged as a leading focus of medical aesthetics in recent years.1-4 An increasing patient demand for long-lasting, …
Dr Nicole Chiang presents a case study on the treatment of female pattern hair loss using platelet-rich-plasma Platelet-rich plasma (PRP) was first described in haematology in the 1970s as a small volume of plasma containing higher concentrations of platelets than …
Dr Priya Shah explores the difficulty in determining the efficacy of platelet-rich plasma as a monotherapy for skin ageing
Aesthetic supplier and training provider 4T Medical has launched its new platelet-rich plasma (PRP) kit.
Aesthetic pharmaceutical company Croma Pharma has announced its Croma Academy Day for practitioner education this month.
Training provider Acquisition Aesthetics is collaborating with platelet-rich plasma (PRP) company RegenLab on a new course.
Aesthetic manufacturer Croma-Pharma partnered with the British Association of Cosmetic Nurses (BACN) at their regional meeting.
Aesthetic supplier Wigmore Medical invited 100 medical aesthetic practitioners and 13 companies to the Royal Society of Medicine on November 13 for its first London open day since the pandemic.